Assessing the relationship between Iraqi patients' risk of type 2 diabetes and genetic variations in the CYP17A1 gene

Authors

  • Saleh Abd-Qader Abed
  • Ammar Ahmed Sultan Biology department, Faculty of education for pure science, University of Diyala, Baaquba, Iraq.

DOI:

https://doi.org/10.5281/zenodo.10251838

Keywords:

Cytochrome P450, Genotype distribution, Molecular genetics, Odd ratio

Abstract

The characteristic feature of type 2 diabetes mellitus is a rise in blood sugar (glucose) because of insufficient insulin secretion from pancreatic beta cells, ineffective insulin, somatic cell resistance to insulin, or a combination of these factors. The purpose of this study is to assess the impact of CYP17A1 genetic polymorphisms at the rs6163 and rs6162 variant sites on the risk of type II diabetes. The tenth chromosome's mitochondrial CYP17A1 gene is linked to high blood pressure, insulin resistance, and polycystic ovarian syndrome in addition to encoding a crucial enzyme involved in the manufacture and metabolism of steroid hormones. As the homologous genetic genotype AA and allele A showed an increase in the diabetic group, the study's results demonstrated the presence of genetic heterogeneity at the site of heterogeneity C/A rs6163 in the gene CYP17A1. This is a causative factor according to the Fisher's probability, as the probability value (P = 0.026) as there are significant differences between patients and healthy people, and according to the values of the odd ratio, which reached 9.47 and 2.80, respectively. According to the Fisher's probability, the homogeneous genetic type CC and allele C are protective factors against the disease. The probability value was (P = 0.055), indicating that there are significant differences between patients and healthy individuals. The odds ratio values reached 0.24 and 0.36. According to the probability of Frisher, the homogeneous genotype GG and allele G are protective factors; the probability value is (P = 0.226), where there are no significant differences between patients and healthy individuals, and according to the value of the odds ratio, which amounted to (0.44 and 0.42), respectively. The study's results indicated the presence of genetic heterogeneity at the site of the heterogeneity, rs6162 G/A. According to the Fisher's probability, genotype AA and allele A are regarded as causal agents; the corresponding odds ratio values were 2.80 and 9.47, respectively. The p-value was found to be (P = 0.026).

References

Akhtar, N., Kamran, S., Singh, R., Malik, R. A., Deleu, D., Bourke, P. J., Joseph, S., Santos, M. D., Morgan, D. M., & Wadiwala, F. M. (2019). The impact of diabetes on outcomes after acute ischemic stroke: a prospective observational study. Journal of Stroke and Cerebrovascular Diseases, 28(3), 619–626.

Al-Rubae’i, S. H. N., Naji, T. S., & Turki, K. M. (2017). Common variation of the CYP17 gene in Iraqi women with endometriosis disease. Genomics Data, 11, 55–59.

Jaacks, L. M., Siegel, K. R., Gujral, U. P., & Narayan, K. M. V. (2016). Type 2 diabetes: A 21st century epidemic. Best Practice & Research Clinical Endocrinology & Metabolism, 30(3), 331–343.

Kene, K., Wondimnew, T., Welde, M., Mateos, T., Adugna, T., Gerema, U., Abdisa, D., & Abera, D. (2021). Prevalence and determinants of Impaired Serum Creatinine and Urea among type 2 diabetic patients of jimma medical center, Jimma, Southwestern Ethiopia, 2019. Endocrine and Metabolic Science, 3, 100096.

Kousar, S. (2019). Type 1 Diabetes: Causes, symptoms and treatments, review with personal experience. Current Research in Diabetes & Obesity Journal, 11(4), 77–83.

Ochoa-Guzmán, A., Guillén-Quintero, D., Muñoz-Hernández, L., García, A., Díaz-Díaz, E., Pérez-Méndez, O., Rodríguez-Guillén, R., Mitre-Aguilar, I. B., Zentella-Dehesa, A., & Aguilar-Salinas, C. A. (2021). The influence of high-density lipoprotein (HDL) and HDL subfractions on insulin secretion and cholesterol efflux in pancreatic derived β-cells. Journal of Endocrinological Investigation, 44, 1897–1904.

Qin, P., Lou, Y., Cao, L., Shi, J., Tian, G., Liu, D., Zhou, Q., Guo, C., Li, Q., & Zhao, Y. (2020). Dose‐response associations between serum creatinine and type 2 diabetes mellitus risk: A Chinese cohort study and meta‐analysis of cohort studies. Journal of Diabetes, 12(8), 594–604.

Ragia, G., Petridis, I., Tavridou, A., Christakidis, D., & Manolopoulos, V. G. (2009). Presence of CYP2C9* 3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas. Pharmacogenomics, 10(11), 1781–1787.

Regufe, V. M. G., Pinto, C. M. C. B., & Perez, P. M. (2020). Metabolic syndrome in type 2 diabetic patients: A review of current evidence. Porto Biomedical Journal, 5(6).

Rezgoun, M. L., El Khour, D., Bendaoud, H., & Chellat, D. (2023). CYP17A1 (rs74357) polymorphism and polycystic ovary syndrome risk: A systemic review and meta-analysis. Acta Bio Medica: Atenei Parmensis, 94(4).

Skibola, C. F., Lightfoot, T., Agana, L., Smith, A., Rollinson, S., Kao, A., Adamson, P., Morgan, G. J., Smith, M. T., & Roman, E. (2005). Polymorphisms in cytochrome P450 17A1 and risk of non‐Hodgkin lymphoma. British Journal of Haematology, 129(5), 618–621.

Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., & Hadjadj, S. (2007). A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 445(7130), 881–885.

Wang, M., Wang, H., Zhao, H., Li, L., Liu, M., Liu, F., Meng, F., & Fan, C. (2019). Prevalence of CYP17A1 gene mutations in 17α-hydroxylase deficiency in the Chinese Han population. Clinical Hypertension, 25, 1–9.

Yamada, T., Nakayama, M., Shimizu, T., Nonen, S., Nakai, Y., Nishimura, K., Fujio, Y., Okuyama, A., Azuma, J., & Nonomura, N. (2013). Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy. International Journal of Clinical Oncology, 18, 711–717.

Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019). Insulin resistance: Review of the underlying molecular mechanisms. Journal of Cellular Physiology, 234(6), 8152–8161.

Downloads

Published

2023-12-03

How to Cite

Abd-Qader Abed , S. ., & Ahmed Sultan, A. (2023). Assessing the relationship between Iraqi patients’ risk of type 2 diabetes and genetic variations in the CYP17A1 gene. Journal of Wildlife and Biodiversity, 7(Special Issue), 449–458. https://doi.org/10.5281/zenodo.10251838